IMAX spent the year signing fresh premium screen deals and leaning into blockbuster events like The Odyssey, but the most concrete shift was simple. For IMAX shareholders, the return over the past year was 35.8%, including dividends. If you had been weighing a buy on 11 November 2025, you would have needed a view on whether Asia Pacific screen additions and immersive tech bets justified that outcome long before the headlines confirmed record box office and wider margins.
The easy part of this move is behind IMAX. Zero in on 32 high quality undervalued stocks for companies trading below our estimates.
The Two IMAX Stories Investors Were Arguing About
The shares cost US$35.13 at the start of the period, so anyone looking at IMAX then had to decide which story sounded more realistic.
The bullish narrative saw immersive formats and Asia Pacific demand as the engine, backed by a Fair Value of US$38. This was a price level implied by assumptions of faster system installations and higher margins from alternative content like live concerts and gaming.
The more cautious view pinned Fair Value at US$32.82, a price suggested by expectations for expanding screens and recurring cash flows. However, there was real concern that streaming habits and at home entertainment could cap long term theater attendance.
What The Results Changed For The IMAX Debate
The clearest new fact for IMAX was the Q3 2026 report. Revenue was US$174.552 million with net income of US$113.805 million, compared with US$106.654 million and US$20.657 million a year earlier. Net margin moved from 19.4% to 65.2%. That scale of profitability supported the optimistic case on margins, while the earlier revenue decline flagged in Q1 kept the cautious view alive on box office volatility.
The lesson here is simple. When a story hinges on premium economics, do not just track headline revenue. Watch net margin and absolute profit in the filings and test whether they move in the same direction as the high return narrative.
What IMAX’s Current Price Already Bakes In
IMAX now trades at US$48.81 after a 35.8% gain over the past year. The analyst consensus Narrative on Simply Wall St suggests its Fair Value sits above that level, based on a business case rather than a claim about where the share price will go next.
The Narrative focuses on expanding premium screens, a broader content pipeline and high operating leverage feeding through to cash generation. Anyone paying today’s price has to judge whether IMAX can keep turning more screens and premium releases into sustained high incremental margins and recurring free cash flow.
"The main thing that has to go right is that IMAX continues to convert its underpenetrated screen opportunity, strong box office titles such as The Odyssey, and growing local language and alternative content into sustained high incremental margins and recurring free cash flow."
One Narrative disagrees with today's price. → See where this Narrative says IMAX should trade
How Could You Get There Earlier?
You may be late to this rally, but that does not have to mean arriving late to every opportunity. Start with companies whose prices leave room for a different view of their future. Here are three trading below our estimates.
- Company 1 - 32% below our estimate - targets long lived gold reserves while managing higher operating costs and geopolitical exposure.
- Company 2 - 40% below our estimate - converts shorter cycle subsea opportunities into higher margin installation and long duration services work.
- Company 3 - 44% below our estimate - leans on AI data centre demand that depends on retaining GPU and software stack dominance.
Three companies from the same screener. Open all 23 companies with the balance sheet to back it up →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com